👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Blue Cross Blue Shield settles US health provider class action for $2.8 billion

Published 10/14/2024, 06:55 PM
Updated 10/14/2024, 07:01 PM
© Reuters. A file photo of a healthcare provider in California, U.S., January 18, 2018. REUTERS/Mike Blake

By Mike Scarcella

(Reuters) -Insurer Blue Cross Blue Shield has agreed to pay $2.8 billion to resolve antitrust class action claims by hospital systems, physicians and other health providers alleging they were underpaid for reimbursements, the plaintiffs said in an Alabama federal court filing on Monday.

The settlement is the largest ever for a healthcare antitrust case, they added.

Blue Cross Blue Shield denied the allegations in a statement, but said it agreed to the settlement and make operational changes to "put years of litigation behind us."

The providers' lead attorneys, Joe Whatley and Edith Kallas, said in a statement the proposed settlement would "transform" the BlueCard program through which providers submit claims.

The agreement is subject to approval from U.S. District Judge R. David Proctor.

The health providers first sued in 2012, claiming Blue Cross and its affiliates divided the country into exclusive areas where they did not compete with each other. The lawsuit said the nationwide conspiracy increased the cost of insurance and drove down reimbursements.

Under the settlement, Blue Cross will create a system-wide information platform facilitating member benefits, eligibility verification and claims tracking that the attorneys said would lead to more transparency, efficiency and accountability.

The settlement will also give providers more contracting opportunities with Blue Cross.

Blue Cross will spend hundreds of millions of dollars implementing the non-monetary part of the settlement, the filing said.

The settlement covers U.S. healthcare service providers, including hospitals and some doctors, with Blue plan patients between July 2008 and October 2024.

© Reuters. A file photo of a healthcare provider in California, U.S., January 18, 2018. REUTERS/Mike Blake

The lawyers said they would ask for up to $700 million in legal fees from Blue Cross.

Blue Cross agreed in 2020 to pay $2.7 billion to resolve related antitrust claims from commercial and individual subscribers. The U.S. Supreme Court upheld that deal in June.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.